Lesten

Quick links to important sections

Lesten

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lesten

Quick Facts

Property Description
Active ingredients Enalapril, Hydrochlorothiazide
Form Oral tablets
Pharmacological class Antihypertensive agents (ACE inhibitor + Diuretic)
Common use Systemic management of high blood pressure
Origin Synthetic

What Type of Medicine is Lesten and What Does It Contain?

Lesten is a prescription-only, fixed-dose combination medicine classified as an antihypertensive agent, primarily used for the long-term, systemic management of high blood pressure in adults. It is a synthetic compound supplied as an oral dosage form, specifically as tablets. The preparation's composition includes two distinct active ingredients: Enalapril maleate, an Angiotensin-Converting Enzyme (ACE) inhibitor, and Hydrochlorothiazide (HCTZ), a thiazide diuretic. This combination is clinically recognized for its synergistic approach to stabilizing blood pressure and its efficacy relative to single-agent therapy.

The Dual Pharmacological Class of Lesten

Lesten's function stems from its dual pharmacological identity, employing two different methods to help manage blood pressure. The Enalapril component works to help relax the blood vessels, making it easier for blood to flow. Simultaneously, the Hydrochlorothiazide component acts as a "water pill," encouraging the kidneys to remove excess salt and water from the body, thereby reducing the total fluid volume in the bloodstream. This approach of combining an ACE inhibitor with a diuretic is a well-established strategy. The primary purpose is to secure effective, long-term maintenance of reduced blood pressure by addressing both vascular resistance and fluid balance simultaneously.

Regulatory References

  1. MedlinePlus Drug Information
  2. NICE guideline on hypertension

What side effects are possible with Lesten?

Possible Side Effects and Safety Information

The safety profile of Lesten (Enalapril/Hydrochlorothiazide) is defined by officially documented reactions categorized by frequency and the physiological system affected.

Frequency Classification (Regulatory Terms) Examples of Officially Listed Effects
Common (up to 1 in 10 patients) Dizziness, Headache, Cough, Nausea, Fatigue (or weakness)
Uncommon (up to 1 in 100 patients) Orthostatic Hypotension, Palpitations, Diarrhea, Rash, Muscle cramps

Serious adverse events are explicitly highlighted in the regulatory labeling. The most serious and life-threatening reaction documented is Angioedema, which involves swelling of the face, tongue, and throat and can occur at any time during treatment. Other serious documented reactions include Fetal Toxicity (if used during pregnancy, especially the 2nd and 3rd trimesters), severe Hypotension, Acute Renal Failure, and Hepatic Failure.

Safety-Related Restrictions and Patterns

Official labeling defines specific constraints for use and highlights time-related risk patterns. Use is contraindicated in patients with a history of Angioedema related to an ACE inhibitor, Anuria (inability to pass urine), or known allergy to sulfa-derived drugs.

  • Population Notes: The medicine is contraindicated during the 2nd and 3rd trimesters of pregnancy due to fetal risk. Caution is noted for patients with renal impairment or hepatic impairment.
  • Exposure Patterns: Effects like hypotension are often noted as more likely after the initial dose or following a dose increase. An increased risk of Non-Melanoma Skin Cancer is documented with long-term exposure to the Hydrochlorothiazide component.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Lesten (Enalapril/Hydrochlorothiazide) is officially documented by regulatory authorities to present with serious physiological consequences stemming from its two active components.

Documented Overdose Manifestations

Component Primary Clinical Manifestations
Enalapril Marked hypotension (severely low blood pressure) and stupor (altered mental state).
Hydrochlorothiazide Clinical signs of dehydration and electrolyte depletion, specifically hypokalemia and hyponatremia.

Severe Outcomes and Required Actions

Serious or life-threatening outcomes documented in regulatory labeling include circulatory collapse resulting from profound hypotension, and the potential for severe cardiac arrhythmias which can be exacerbated by hypokalemia. Management is symptomatic and supportive, as no specific antidote is available.

When Immediate Medical Help is Required

Regulatory documents explicitly mandate that individuals seek emergency medical attention immediately or contact a Poison Control Center for any suspected overdose. Emergency services must be called if the individual has collapsed, had a seizure, or cannot be awakened. Overdose management may require advanced procedures like intravenous volume expansion or hemodialysis to remove the Enalapril metabolite.

Therapeutic Uses of Lesten

What Lesten Treats: Main Uses and Benefits

The primary therapeutic benefit of Lesten (Epinephrine) is considered relevant to provide supportive relief during acute, critical episodes. This medication is commonly used across conditions marked by increased physiological stress. Its application is relevant when supportive symptom management is appropriate for circulatory and respiratory emergencies.

Lesten is used for managing the symptom clusters of severe type I allergic reactions (anaphylaxis), acute respiratory distress (such as severe asthma or croup), and hypotension associated with shock.

“Lesten may assist with easing the acute intensity of a reaction, contributing to the patient's stability when symptoms are most disruptive.”

Quick Fact: Relief for Acute Functional Strain

This supportive relief helps contribute to a sense of stability when functional stability becomes affected, offering symptomatic relief that helps patients cope more steadily with difficult episodes. It may assist with supporting the body during systemic imbalance and is relevant for easing symptoms related to breathing discomfort.

Eligibility and Restrictions for Use

Who Can and Cannot Use Lesten?

Lesten (Enalapril/Hydrochlorothiazide) is approved for use in adults with essential hypertension, but regulatory documents define specific populations for whom use is either restricted or strictly prohibited.

Contraindications and Non-Eligibility

Use of Lesten is contraindicated and must be avoided in patients with a known hypersensitivity to enalapril, hydrochlorothiazide, or any sulfonamide-derived drug. The medicine is also strictly prohibited for individuals with a history of angioedema related to previous ACE inhibitor use, as well as those with anuria or severe renal impairment (creatinine clearance less than 30 mL/min).

Population Group Eligibility Status
Pediatric Patients Not Recommended. Safety and efficacy are not established.
Pregnancy Contraindicated in the 2nd and 3rd trimesters; Not Recommended in the 1st.
Lactation Not Recommended.
Concomitant Therapy Contraindicated with sacubitril/valsartan and aliskiren (in specific patients).

Eligibility also requires caution for patients with severe hepatic impairment or pre-existing conditions like gout or Systemic Lupus Erythematosus, as use may be restricted.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Lesten as described in government regulatory sources.


Formal Contraindications and Restrictions

Co-administration with Sacubitril/Valsartan is strictly contraindicated due to the increased risk of angioedema; a separation of 36 hours is required when switching to or from the ACE inhibitor component. Use with Aliskiren is also contraindicated for patients with diabetes mellitus or moderate to severe renal impairment (GFR < 60 mL/min/1.73 m²) as this constitutes dual blockade of the Renin-Angiotensin System. Co-administration with mTOR Inhibitors (e.g., Temsirolimus, Sirolimus) is officially associated with an increased risk of angioedema.


Pharmacodynamic and Exposure Alterations

The diuretic component can cause reduced renal clearance of Lithium, which is documented as creating a high risk of Lithium toxicity. Agents that increase serum potassium, such as potassium supplements or certain potassium-sparing diuretics, are known to increase the risk of hyperkalemia. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) may both reduce the antihypertensive effects and increase the risk of renal function decline. Furthermore, Cholestyramine and Colestipol resins officially cause reduced absorption of the Hydrochlorothiazide component, which results in lower systemic exposure. The label specifies that Amiodarone may increase the level of Hydrochlorothiazide by basic drug competition for renal tubular clearance.


Substance Interactions

The regulatory label notes that co-administration with Alcohol, Barbiturates, or Narcotics may potentiate the risk of orthostatic hypotension.

Mechanism of Action

How Lesten Works

Lesten exerts its pharmacodynamic effects through molecular modulation within specific signaling pathways. Its mechanism of action begins with interaction at a class of cell-surface receptors central to mediating rapid cellular communication. Lesten acts as an allosteric modulator, binding to a distinct site on the receptor complex, which modifies the receptor's conformation and its affinity for endogenous neurotransmitters or mediators.

This engagement initiates an altered signaling sequence by modulating the associated G-protein activity. The resulting intracellular cascade modifies the formation of specific second messengers, consequently adjusting the phosphorylation state of downstream effector proteins. This action alters the signaling threshold of these pathways, influencing the activity of processes driven by distinct signaling patterns. Ultimately, this leads to an alteration in the net signal throughput within the targeted biological systems.

Dosage and Administration Information

How Lesten is Used: Administration Guidelines

Lesten, a fixed-dose oral tablet combining Enalapril and Hydrochlorothiazide (HCTZ), is intended for the long-term management of high blood pressure. Its use is governed by specific guidelines that define the context, frequency, and administration conditions of the treatment, strictly excluding it from initial therapy.


Administration Context and Regimen

The medicine is designed for once-daily oral administration as maintenance therapy. It is typically used as a step-up treatment when a patient’s blood pressure is not adequately controlled with Enalapril alone, or as a convenient replacement therapy when a patient has been stabilized on the individual components in the same proportions. The tablet must be swallowed whole and should be taken at approximately the same time each day to maintain consistent blood concentration levels.

Feature Use Guideline
Route of Administration Oral
Dosing Frequency Once daily
Timing Relative to Meals May be taken with or without food

Dosage Constraints and Special Populations

Lesten is not intended for use in the initial dose-finding (titration) phase of hypertension treatment, as dosage adjustment should be performed using the individual components. The use of the fixed combination is not recommended for patients with severe renal impairment (creatinine clearance < 30 mL/min). Furthermore, the safety and effectiveness of Lesten have not been established for use in children under 18 years of age. If a dose is missed, it is generally recommended to skip the missed dose and return to the regular once-daily schedule, emphasizing that a double dose should not be taken.

Recent Clinical Evidence

Research Evidence Overview

This section summarizes the structure and nature of the official research, including key clinical trials and meta-analyses, that regulatory bodies rely upon for the approval of Lesten (a fixed-dose combination of Enalapril and Hydrochlorothiazide). This overview describes what types of studies exist and what they have examined, but it does not provide clinical guidance or treatment recommendations.


Evidence for Use in Managing High Blood Pressure

The research for Lesten was primarily evaluated in Randomized Controlled Trials (RCTs). These studies were used in research exploring how blood pressure readings change over defined time intervals. Lesten was studied for the management of high blood pressure, especially in adult patients whose pressure was not adequately controlled by taking a single ingredient (either Enalapril or Hydrochlorothiazide) alone. The main focus of these trials was to monitor the magnitude of change in systolic and diastolic blood pressure measurements over periods generally ranging from 4 to 12 weeks.

Studies reported measurements that described patterns related to blood pressure changes when the combination treatment was used, compared to patients receiving a placebo or either single ingredient. Research highlights changes measured during the study period, and studies report patterns showing that more patients achieved the predefined blood pressure goals when taking the combination drug compared to those on monotherapy. These findings describe patterns observed in the studies conducted under specific, controlled conditions.

Long-Term Studies and Durability of Response

For medicines that manage chronic conditions, research often explores whether long-term studies can contribute to understanding outcomes related to physical discomfort and systemic or functional imbalance. Long-term follow-up data for the sustained nature of blood pressure control is generally derived from the evidence for the individual drug classes (ACE inhibitors and diuretics).

While the combination itself was observed in trials lasting several weeks, evidence regarding the reduction in major adverse cardiovascular events, such as stroke or heart attack over many years, stems from the large, long-running clinical trials that have evaluated the individual components. Research suggests a link between sustained blood pressure control and the reduction of long-term cardiovascular risk factors. Lesten was studied for its role in blood pressure control, and these findings contribute to the broader evidence landscape. However, specific, multi-year outcome data for this exact fixed-dose ratio combination are still emerging.

What is Still Uncertain About Lesten's Research Base

The evidence landscape, while extensive for the treatment of high blood pressure, always contains areas where more research is needed. One key limitation is that comparative evidence is lacking for long-term outcomes specifically comparing Lesten's fixed combination to other common dual-therapy combinations used for hypertension management. Additionally, data for certain groups remain insufficient; for example, there is limited information for long-term outcomes in certain narrow patient subgroups, and the pediatric population has not been extensively studied for this specific combination.

Frequently Asked Questions (FAQ)

Common questions about Lesten (FAQ)


Q: Does Lesten have a black box warning from the FDA?

The FDA label for the ACE inhibitor component of Lesten is described as containing a Boxed Warning. This warning highlights the fetal toxicity risk, which is described as potentially causing injury and death to a developing fetus when used during the second and third trimesters of pregnancy.


Q: Can Lesten affect the results of lab tests (like bloodwork)?

Regulatory documents indicate the medicine may interfere with the results of certain laboratory tests. For instance, the medicine can affect tests used to measure parathyroid function or protein-bound iodide. The label suggests that testing facilities should be informed that a patient is taking this medication before conducting certain lab work.


Q: Does Lesten come in different strengths or forms (like liquid or tablet)?

Lesten is supplied as an oral tablet, which is its official dosage form. Regulatory labels confirm that this fixed-dose combination product is generally available in different fixed-dose combinations (strengths) of its two active ingredients.


Q: Does Lesten interact with caffeine or alcohol?

Official documentation notes that using Lesten with alcohol may increase the risk of orthostatic hypotension (dizziness upon standing). However, there is no consistent specific warning regarding an interaction with caffeine documented in the primary regulatory sources.


Q: Are there any known food items that should be avoided while taking Lesten?

Official regulatory guidance advises caution regarding products that affect potassium levels. This includes avoiding the use of potassium supplements or salt substitutes containing potassium, as the medicine’s ACE inhibitor component already has the potential to increase potassium levels in the blood. Official guidance highlights that dietary adjustments, such as limiting foods high in potassium, are sometimes suggested due to the medicine's potential to increase potassium levels.


Q: What is the average duration of a course of Lesten?

Regulatory information indicates that Lesten is prescribed for the long-term or chronic management of high blood pressure. The medicine is intended to be continued as prescribed to maintain consistent blood pressure control. Since the medicine is used for chronic management, official guidelines recommend that any changes to the regimen occur under the supervision of a healthcare professional.


Q: How long does it typically take for a person to notice the effects of Lesten?

According to the official clinical pharmacology information, the blood pressure-lowering effect typically starts within about one hour after taking a dose. The peak reduction in blood pressure usually occurs within four to six hours, though the full, long-term effect of treatment may take several weeks to establish.


Q: Is Lesten known to cause weight gain or weight loss?

Weight changes are not commonly listed as an official adverse reaction in product labeling for Lesten. However, the medicine's diuretic component can affect fluid and electrolyte balance, and these changes may sometimes be associated with measurable changes in body weight.


Q: Are there any specific lifestyle factors (like diet or exercise) that affect how Lesten works?

Regulatory guidance advises patients to take steps to avoid overheating or becoming dehydrated while taking this medicine. Excessive sweating, severe diarrhea, or vomiting can lead to fluid and electrolyte loss. Regulatory guidance describes the importance of maintaining fluid and electrolyte balance, and instructions from a healthcare professional regarding fluid intake are suggested during such situations.


Q: What happens if a person stops taking Lesten suddenly?

Official pharmacological data indicates that abrupt cessation of the Enalapril component has generally not been linked to a sudden or rapid increase in blood pressure above baseline levels. Since the medicine is used for chronic management, official guidelines recommend that any changes to the regimen occur under the supervision of a healthcare professional.


Q: Is Lesten considered a controlled substance?

No, Lesten is classified as a prescription medicine used to manage blood pressure. According to federal regulatory databases, Lesten is not listed or classified as a controlled substance.


Q: How long does Lesten stay in a person's system?

Official clinical pharmacology details the half-life of Lesten’s active components. The effective half-life for the active form of the ACE inhibitor component (Enalaprilat) is approximately 11 hours. The half-life for the diuretic component (Hydrochlorothiazide) is reported to be between 5.6 and 14.8 hours.


Q: Are there any known issues with taking Lesten at the same time as cold or allergy medicine?

Official patient information often contains a general warning that some over-the-counter products may contain ingredients that could potentially raise blood pressure. Official guidance suggests that consultation with a healthcare professional is appropriate before taking nonprescription cold or allergy medicines while on Lesten.


Q: Do older adults use Lesten differently than younger adults?

Regulatory documents suggest that caution may be necessary when initiating treatment in the elderly, typically defined as those over 65 years of age. Some older patients may show a higher response to the individual components, and official guidelines suggest that the initial administration of the Enalapril component may require adjustment.


Q: Are there any restrictions on driving or operating machinery while taking Lesten?

Official warnings state that Lesten may cause dizziness or lightheadedness, which can impair a person's ability to drive or use machines. Official documents advise that, due to the potential for impaired ability, patients should know how the medicine affects them before driving or operating machinery.


Q: Can Lesten cause changes in mood or sleep patterns?

Less common effects listed in regulatory adverse reaction reports for the medicine's components sometimes include changes in sleep patterns, such as trouble sleeping (insomnia) or abnormal dreams. Other central nervous system effects, including changes in mood, have also been reported.


Q: Is it true that Lesten is less effective over time?

Official pharmacological data indicates that the blood pressure-lowering effects of the Enalapril component have been shown to continue during long-term therapy. This suggests that the medicine maintains its effectiveness over sustained periods of use.


Q: Is Lesten a generic or a brand-name medicine?

The specific combination of enalapril and hydrochlorothiazide is available under a brand name and is also supplied as an officially approved, lower-cost generic medication. Both formulations are regulated by health authorities.


Q: Does Lesten cause light sensitivity?

Yes, regulatory patient information warns that the medicine may make a person more sensitive to the sun and may increase the risk for non-melanoma skin cancer with long-term exposure. Official guidance related to this risk mentions the use of protective clothing and sunscreen while outdoors.


Q: Why do people sometimes say Lesten makes them feel [specific, non-clinical side effect like 'foggy']?

The subjective feeling of 'foggy' is not an officially listed side effect. However, the regulatory adverse reaction lists do include objective effects such as dizziness, lightheadedness, and fatigue, which may be subjectively experienced or described by patients as feeling 'foggy'.


Q: Does Lesten impact fertility?

Official product information focuses primarily on the contraindication in pregnancy, but some adverse reaction lists note that the components have been associated with issues like a decreased interest in sexual activity or erectile dysfunction as less common effects.


Q: What should be done if an interaction with Lesten is suspected?

Official patient guidance universally advises that if a patient suspects they are experiencing symptoms of a significant drug interaction or a serious adverse event, contact with a healthcare provider is appropriate immediately.

How should Lesten be stored and disposed of?

How to Store and Dispose of Lesten

Lesten (enalapril/hydrochlorothiazide) must be stored according to regulatory requirements to ensure its chemical stability.

Storage Requirements

The medicine requires storage at controlled room temperature, specifically maintained between 20 C and 25 C (68 F and 77 F). The product must be kept in its original container and the container kept tightly closed to protect the tablets from moisture and excessive heat. The official label requires that the product not be frozen.

Always keep Lesten out of the sight and reach of children.

Disposal Instructions

Unused or expired Lesten should be disposed of through a designated medicine take-back program. If no program is available, the product can be mixed with an unappealing substance (like dirt or coffee grounds) and sealed in a bag for disposal in household trash. Do not flush Lesten down the toilet or pour it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lesten found in:

A-Z Index: